Skip to main content



Legend
Presentation Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation
Foundation
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts

Full Schedule

Full Schedule

  • Friday, October 24, 2025
  • 10:00 AM - 6:00 PM  PT
    Speaker Ready Room
  • 1:30 PM - 3:00 PM  PT
    AABB Foundation Research & Development Summit
  • 2:00 PM - 6:00 PM  PT
    REGISTRATION
  • 3:30 PM - 5:00 PM  PT
    Assessor LIVE Session
  • 5:00 PM - 6:30 PM  PT
    Biotherapies Networking Reception
  • 6:00 PM - 7:30 PM  PT
    AABB Foundation Reception - A Party with a Purpose!
  • Saturday, October 25, 2025
  • 6:30 AM - 7:00 PM  PT
    REGISTRATION
  • 7:00 AM - 8:00 AM  PT
    Molecular Testing Standards Committee Meeting
  • 7:00 AM - 6:00 PM  PT
    Speaker Ready Room
  • 7:30 AM - 8:30 AM  PT
    Coding and Reimbursement Committee Meeting
  • 7:30 AM - 5:30 PM  PT
    Bookstore and AABB Central
  • 7:30 AM - 6:00 PM  PT
    Coat and Luggage Check
  • 8:00 AM - 8:15 AM  PT
    Cord Blood Connect Welcome
  • 8:00 AM - 5:00 PM  PT
    T-shirt and Packet Pickup: Run for Research and Sleep-in for Research
  • 8:15 AM - 9:15 AM  PT
    CBC: The Role of MSC´s in the Development of Regenerative Cell Therapies
  • 8:15 AM - 9:15 AM  PT
    Quality Agreements in Cell Therapy: Building Successful Partnerships
  • 8:15 AM - 9:15 AM  PT
    Reducing O Negative RBC Overutilization in Pediatric Transfusion Medicine: Overcoming Challenges
  • 8:15 AM - 9:15 AM  PT
    The Peer-review Publication Process - How to Dip Your Toe in the Author and Reviewer Waters
  • 8:15 AM - 9:15 AM  PT
    Understanding Generative AI: A Friendly Introduction for Medical Professionals
  • 8:15 AM - 9:15 AM  PT
    AM25-ST-24-L - Investigation of Phenotype/genotype Discrepancies Identified Novel RHCE*cE(1040C) and KEL*K(1712C) Alleles Emphasizing Need for Two Methods for Determining Donor Antigen Status
  • 8:15 AM - 9:15 AM  PT
    AM25-ST-24-L - Investigation Prompted by Antibodies to High-Incidence Rh Antigens Reveals RH Haplotypes Consisting of Three Variant Alleles, With Two and One RHCE Across Three Generations in a Congolese Family
  • 8:15 AM - 9:15 AM  PT
    AM25-ST-24-L - Novel RHCE*ce(510C) Allele Reactive with Some Anti-D Reagents Shows Importance of Careful Selection of Reagents Used for Routine Prenatal and Pretransfusion RhD Typing
  • 8:15 AM - 9:15 AM  PT
    AM25-ST-24-L - Oral Abstract Session - Novel RHCE Variants
  • 8:15 AM - 9:15 AM  PT
    AM25-ST-24-L - Three Unique RHCE Variants Causing Negative Phenotypes
  • 8:15 AM - 12:15 PM  PT
    THOR
  • 9:30 AM - 10:30 AM  PT
    Building Trust-Based Teams: A Strategic Imperative for Leaders
  • 9:30 AM - 10:30 AM  PT
    CBC: Cord Blood for Regenerative Medicine
  • 9:30 AM - 10:30 AM  PT
    Choose Your Own Adventure: Spooky Serology, Mysterious Molecular, & Eerie Incompatibility
  • 9:30 AM - 10:30 AM  PT
    Improving Recognition and Reporting of Transfusion Reactions: Data-Driven Insights and Quality Improvement Strategies
  • 9:30 AM - 10:30 AM  PT
    Mock Grant Review
  • 9:30 AM - 10:30 AM  PT
    AM25-ST-08-L - Impact of Reconstituted Whole Blood Product Hematocrit on Neonatal Double Volume Exchange Transfusions for Hyperbilirubinemia
  • 9:30 AM - 10:30 AM  PT
    AM25-ST-08-L - Oral Abstract Session - Pediatric Transfusion Practice
  • 9:30 AM - 10:30 AM  PT
    AM25-ST-08-L - Pre-Transfusion Platelet Counts and Bleeding in Very Low Birth Weight Infants
  • 9:30 AM - 10:30 AM  PT
    AM25-ST-08-L - Reduced Platelet Transfusion Dosing Safely Limits Infant Platelet Exposure and Decreases Costs
  • 9:30 AM - 10:30 AM  PT
    AM25-ST-08-L - Transfusion Practices in Very Low Birth Weight Infants: Data from the Transfusion in Premature Infants (TIPI) Study
  • 9:30 AM - 11:00 AM  PT
    15 Minute Mentoring: Focus Group Discussions with Mid- to High Level Career Leaders in AABB
  • 10:45 AM - 12:15 PM  PT
    Think Like a Detective: Investigating Quality Issues with Root Cause Analysis (RCA) Tools
  • 10:45 AM - 12:15 PM  PT
    Allogeneic Transplant, Gene Therapy, or the Evolving Drug Landscape in Sickle Cell Disease: Helping Patients Choose Between Options
  • 10:45 AM - 12:15 PM  PT
    Assessor Townhall: Assessment Readiness-Get Ready and Stay Ready
  • 10:45 AM - 12:15 PM  PT
    CBC: Innovative Approaches in Cord Blood Transplantation: Clinical Outcomes and New Strategies
  • 10:45 AM - 12:15 PM  PT
    Solve It Scenarios in Cellular Therapy
  • 10:45 AM - 12:15 PM  PT
    AM25-ST-01-L - Diversity of RH and Antibody Development Following Transfusion in the Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) Brazil Sickle Cell Disease Cohort
  • 10:45 AM - 12:15 PM  PT
    AM25-ST-01-L - Low Affinity RBC Autoreactive B Cells Escape Deletion in the Bone Marrow of Mice
  • 10:45 AM - 12:15 PM  PT
    AM25-ST-01-L - Oral Abstract Spotlight Session - Discoveries in the Science of Immunohematology
  • 10:45 AM - 12:15 PM  PT
    AM25-ST-01-L - Red Cell Antibody and Antigen Patterns in Patients with Sickle Cell Disease: A Multi-Center Analysis
  • 10:45 AM - 12:15 PM  PT
    AM25-ST-01-L - Transfusion Induced Alloantigen-Specific CD8+ T Cells Cause Platelet Refractoriness in Mice.
  • 12:00 PM - 1:00 PM  PT
    Selection of Abstracts Committee (SoAc) Meeting
  • 12:05 PM - 1:45 PM  PT
    Transfusion Fellowship Directors Subsection Meeting
  • 12:10 PM - 1:45 PM  PT
    Technical Practices, Serology and Genomics Subsection Meeting
  • 12:15 PM - 1:30 PM  PT
    AABB Foundation Research Symposium & Luncheon
  • 12:30 PM - 1:30 PM  PT
    Donor History Task Force/Regulatory Affairs Joint Meeting
  • 12:30 PM - 1:30 PM  PT
    New Member and First Time Attendee Lunch
  • 1:45 PM - 2:45 PM  PT
    CBC: Opportunities & Challenges the Field of Cord Blood and Birthing Tissues
  • 1:45 PM - 2:45 PM  PT
    Ensuring Safe and Effective Distribution of Advanced Therapies: Unique Perspectives from Pharmacy and Cell Therapy Labs
  • 1:45 PM - 2:45 PM  PT
    Novel Insights into Iron Toxicities in Hematologic Diseases and Related Pharmacological and Gene Therapy Approaches
  • 1:45 PM - 2:45 PM  PT
    The Changing Landscape of Conflict: Armed Services Blood Program Supporting the Warfighter Through Partnerships and Blood Product Innovations
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-21-L - Cost Comparison of In-House Antigen Typing vs Ordering from a Blood Supplier and Analysis of Routine Antigen Screening for C, c, E, and K
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-21-L - Oral Abstract Session - Lessons From the Immunohematology Lab
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-21-L - Protein Variance Affects the Highly Immunogenic Rh Complex in the Red Cell Membrane: A Flow Cytometry Analysis
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-21-L - Transfusion Safety Assessment of RBC Units Containing Unexpected Donor Alloantibody
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-22-L - Are Improvements in Inventory and Patient Blood Management Sufficient? An Analysis of past Performance to Target Realistic Blood Product Budgeting for the Coming Fiscal Year
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-22-L - Beyond the Operating Room: Preservation of Blood Quality and Erythrocyte Function in Postoperative Salvaged Mediastinal Blood
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-22-L - Oral Abstract Session - New Insights to Patient Blood Management
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-22-L - Outcomes of Bloodless Cardiac Surgery in Jehovah’s Witnesses: A Meta-Analysis of Comparative Studies Since 2000
  • 1:45 PM - 2:45 PM  PT
    AM25-ST-22-L - Systematic Obstetric Anemia Prevention Across an Integrated Health Network: Impact of Patient Blood Management Nurse Consultation on Hemoglobin Change
  • 3:00 PM - 4:30 PM  PT
    AABB Opening General Session
  • 4:30 PM - 7:00 PM  PT
    Opening Reception
  • Sunday, October 26, 2025
  • 6:30 AM - 6:30 PM  PT
    REGISTRATION
  • 7:00 AM - 7:45 AM  PT
    Circular of Information Task Force
  • 7:00 AM - 7:50 AM  PT
    Cellular Therapy (CT) Subsections Meeting
  • 7:00 AM - 8:00 AM  PT
    CTSCC- Cellular Therapies Section Coordinating Committee Meeting
  • 7:00 AM - 8:00 AM  PT
    Run for Research
  • 7:00 AM - 8:00 AM  PT
    Sleep-In for Research (not participating in Run)
  • 7:00 AM - 6:00 PM  PT
    Speaker Ready Room
  • 7:15 AM - 8:15 AM  PT
    Clinical Transfusion Medicine Committee Meeting
  • 7:30 AM - 9:00 AM  PT
    Transfusion Editorial Board Breakfast
  • 7:30 AM - 5:30 PM  PT
    Bookstore and AABB Central
  • 7:30 AM - 6:00 PM  PT
    Coat and Luggage Check
  • 8:00 AM - 9:15 AM  PT
    Emerging Ethics and Policy Issues in Cord Blood Therapeutics and Gene Therapies (President’s Session)
  • 8:15 AM - 9:15 AM  PT
    “Blood products as pharmaceuticals: Should that be our goal?” (Tibor Greenwalt Memorial Award and Lectureship)
  • 8:15 AM - 9:15 AM  PT
    Expanding CGT Access: The Role of Blood Centers in Last-Mile Delivery
  • 8:15 AM - 9:15 AM  PT
    Optimization of Postpartum Hemorrhage Management in the Academic and Community Setting
  • 8:15 AM - 9:15 AM  PT
    Planning for Disease X: To Ensure a Safe and Sufficient Blood Supply During the Next Emerging Pathogen Event
  • 8:15 AM - 9:15 AM  PT
    AM25-SN-31-L - Bringing Whole Blood into Inventory: A Look into the Data of a Level One Pediatric Trauma Center
  • 8:15 AM - 9:15 AM  PT
    AM25-SN-31-L - Characterizing 2024 Pre-Hospital Blood Product Administrations in the U.S. using the National EMS Information System
  • 8:15 AM - 9:15 AM  PT
    AM25-SN-31-L - Impact of Low Titer O Positive Whole Blood Implementation on Blood Component Utilization in a Level I Trauma Center
  • 8:15 AM - 9:15 AM  PT
    AM25-SN-31-L - Oral Abstract Session - Insight into Whole Blood and Hemorrhage Management
  • 8:15 AM - 9:15 AM  PT
    AM25-SN-31-L - Whole Blood for Trauma in a Low-Volume Level 1 Trauma Center: A Six-Year Review of Massive Transfusion Practices and Blood Product Utilization
  • 8:15 AM - 3:30 PM  PT
    SBB Exam Prep
  • 9:30 AM - 10:30 AM  PT
    CABP Celebration and Networking
  • 9:30 AM - 4:30 PM  PT
    Exhibit Hall Exhibit Hall Open
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Lyophilized Platelet Extracellular Vesicles Mitigate Intracranial Hemorrhage in a Murine Model of Traumatic Brain Injury by Delivering Hemostatic Proteins and mRNA Cargo
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Nrf2 Activation Modulates Macrophage Polarization and Reduces RBC Alloimmunization in a Transfusion Model
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Platelet Cold Storage Alters Platelet Extracellular Vesicle Phenotype, Inducing Pro-Inflammatory Responses in Monocytes
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Plenary Abstract
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Spray-dried Plasma: A Multi-center, Prospective, Randomized, Dose-escalation Cohort Safety Clinical Trial
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Toll-like Receptor 9 on Donor RBCs Enhances Transfusion Induced Alloimmunity in Mice
  • 10:00 AM - 11:30 AM  PT
    AM25-SN-08-L - Transfusion-Transmissible Infection Prevalence in US Blood Donations: Comparison of 3-month Deferrals to Individual Donor Assessment
  • 11:30 AM - 1:00 PM  PT
    Attendee Lunch
  • 11:30 AM - 1:00 PM  PT
    Biotherapies Sizzling Topics Luncheon
  • 11:30 AM - 1:00 PM  PT
    Immunohematology Reference Laboratory Luncheon
  • 12:00 PM - 1:00 PM  PT
    Meet the Poster Authors
  • 12:00 PM - 1:30 PM  PT
    AABB Interorganizational Disaster Task Force
  • 12:05 PM - 1:45 PM  PT
    Accreditation Program Committee and Standards Program Committee Meeting
  • 12:10 PM - 1:30 PM  PT
    Pediatric Transfusion Medicine Subsection Meeting
  • 12:10 PM - 1:45 PM  PT
    Leadership and Administrative Subsection Meeting
  • 1:15 PM - 2:15 PM  PT
    Patient Blood Management and Transfusion Safety Officer Subsection Meeting
  • 2:30 PM - 3:30 PM  PT
    CBC: Defining Novel Growth Opportunitie for the Cord Blood Field: Lessons Learned & Pathways Forward
  • 2:30 PM - 3:30 PM  PT
    Creating Effective Donor Recruitment Videos Through the Use of Co-Design with Community Partners
  • 2:30 PM - 3:30 PM  PT
    Ensuring Ethical and Regulatory Compliance in Donor Collections for Advanced Therapies
  • 2:30 PM - 3:30 PM  PT
    Implementation of Lab Automation with AI-Driven Software: Best Practices and Benefits
  • 2:30 PM - 3:30 PM  PT
    Prehospital Transfusion: A Collaborative Approach to Implementing the New AABB Standards
  • 2:30 PM - 3:30 PM  PT
    Unexplained Reactivity in Red Cell Antibody Identification: A Way Through
  • 2:30 PM - 3:30 PM  PT
    Update on the Use of Cryopreserved Platelets in Acute Surgical Settings
  • 2:30 PM - 3:30 PM  PT
    AM25-SN-09-L - Changes in Irradiation Practices as Revealed by 2024 Survey
  • 2:30 PM - 3:30 PM  PT
    AM25-SN-09-L - Contemporary Etiologies of Crossmatch Incompatible Red Blood Cell Transfusions
  • 2:30 PM - 3:30 PM  PT
    AM25-SN-09-L - Oral Abstract Session - Non-Infectious Hazards of Blood Transfusion
  • 2:30 PM - 3:30 PM  PT
    AM25-SN-09-L - Systematic Review of Transfusion-associated Graft-versus-host Disease (TA-GVHD): Lessons from the Era of Leukoreduction
  • 2:30 PM - 3:30 PM  PT
    AM25-SN-09-L - Transfusion Safety: A Journey of Establishing Risk Register to Standardized Hemovigilance in a LMIC Healthcare Setting
  • 3:45 PM - 4:45 PM  PT
    CBC: Exploring the Unique Biology of Cord Blood and Birthing Tissues
  • 3:45 PM - 4:45 PM  PT
    FcRN Inhibitors – a New Era for Transfusion Medicine?
  • 3:45 PM - 4:45 PM  PT
    Real-World Models in Action: EMS, Hospital, and Blood Center Partnerships for Prehospital Transfusion
  • 3:45 PM - 4:45 PM  PT
    Should We Bring ABO Genotyping to Our Institution? Things to Know About Taking the Leap
  • 3:45 PM - 4:45 PM  PT
    The Transformative Power of Artificial Intelligence and Machine Learning: From Blood Collectors to the Transfusion Service, a Vein to Vein Approach
  • 3:45 PM - 6:00 PM  PT
    Basic blood biology and mechanisms of immunity in transfusion medicine and biotherapies
  • 3:45 PM - 6:00 PM  PT
    Test Your Blood Bank Knowledge 2025 - Are You up for a Challenge?
  • 5:00 PM - 6:00 PM  PT
    Bridging the Gaps: Hospital–EMS Collaboration for Safe and Effective Prehospital Transfusion
  • 5:00 PM - 6:00 PM  PT
    CBC: Evidence Based Communication in Cord Blood Donation and Banking
  • 5:00 PM - 6:00 PM  PT
    Cold Truths: The Potential Hidden Impact of “Clinically Insignificant” Antibodies in Hypothermic Cardiac Surgery
  • 5:00 PM - 6:00 PM  PT
    Ethical Dilemmas in Compensating Blood Donors: Navigating Global Health Perspectives
  • 5:00 PM - 6:00 PM  PT
    Hospital-Based Blood Collectors Roundtable
  • 5:00 PM - 6:00 PM  PT
    Revolutionizing Donor Selection: Integrating AI, Omics Data, and Large-Scale Cohorts for Improved Cell Therapy Outcomes
  • 5:00 PM - 6:00 PM  PT
    The Four Season of Leadership: A Personal Journey (Hemphill-Jordan Leadership Award)
  • 5:00 PM - 6:00 PM  PT
    When the Refrigerator Is Bare--Innovations from the Blood DESERT Coalition
  • 5:00 PM - 6:00 PM  PT
    AM25-SN-02-L - Effect of Immune Priming with Pre-Omicron SARS-Cov-2 Antigenic Stimuli on Antibody Responses Among Blood Donors with Omicron Infections and Reinfections
  • 5:00 PM - 6:00 PM  PT
    AM25-SN-02-L - HIV Serologic Reactivity in Long-term Treated Persons with HIV According to Timing of ART Initiation and Implications for Blood Safety
  • 5:00 PM - 6:00 PM  PT
    AM25-SN-02-L - Oral Abstract Session - Infectious Diseases & Transfusion Medicine
  • 5:00 PM - 6:00 PM  PT
    AM25-SN-02-L - Seroprevalence of Diphtheria, Tetanus and Pertussis in Australian Blood Donors
  • 5:00 PM - 6:00 PM  PT
    AM25-SN-02-L - The Transfusion-Transmissible Infections Monitoring System (TTIMS): 10 Years of Key Insights in Policy Change and Blood Safety
  • 6:15 PM - 7:30 PM  PT
    Research and Progress (RAPS) - 1
  • 6:30 PM - 8:00 PM  PT
    AABB Volunteer Celebration: Recognizing Volunteers & Exploring Opportunities
  • Monday, October 27, 2025
  • 6:30 AM - 6:30 PM  PT
    REGISTRATION
  • 7:00 AM - 8:30 AM  PT
    Awards Committee Meeting
  • 7:00 AM - 6:00 PM  PT
    Speaker Ready Room
  • 7:30 AM - 5:30 PM  PT
    Bookstore and AABB Central
  • 7:30 AM - 6:00 PM  PT
    Coat and Luggage Check
  • 8:15 AM - 9:15 AM  PT
    CBC: Lightning Talks- The Future of Cord Blood: Bold Visions & Innovations
  • 8:15 AM - 9:15 AM  PT
    Iron Matters: Regulating the Metal That Makes Blood Red (Landsteiner-Alter Award and Lectureship)
  • 9:30 AM - 4:30 PM  PT
    Exhibit Hall Open
  • 10:00 AM - 11:30 AM  PT
    AABB/ASHI Symposium: Exploring Transplant Uncertainties/Conundrums in ABO
  • 10:00 AM - 11:30 AM  PT
    AABB’s Updated Platelet and Red Blood Cell Transfusion Guidelines
  • 10:00 AM - 11:30 AM  PT
    Blood Conservation in the OR: How to Create a Comprehensive Pediatric Patient Blood Management Program
  • 10:00 AM - 11:30 AM  PT
    CBC: A New Era for Cord Blood - The National Cord Blood Network
  • 10:00 AM - 11:30 AM  PT
    Cell Therapy Lab Jeopardy!
  • 10:00 AM - 11:30 AM  PT
    Closing the Divide: Pathways to Engaging Underrepresented Communities in Blood Donation
  • 10:00 AM - 11:30 AM  PT
    Expanding Access, Ensuring Safety: Best Practices in Out-of-Hospital Transfusion
  • 10:00 AM - 11:30 AM  PT
    Lord of the Antibodies
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - AABB Transfusion Medicine Subsection Committee Survey on Directed Blood Donation Practices
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Assessment of Donor Presentation Times Relative to HIV Acquisition During Different Deferral Policies in the U.S. Based on Quantitative Biomarker Testing
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Demographics and Characteristics of First-Time Blood Donors: Comparison of the Implementation of 3-Month Deferral vs Individual Donor Assessment Policies for High-Risk Behaviors
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Oral Abstract Spotlight Session - Cutting Edge Insights into Blood Donations and Allocations
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-04-L - Surge and Sustain: Crisis-Driven Donation Patterns in Whole Blood vs. Apheresis Platelets
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Analysis of Impact to HLA Coverage and Usability of Cord Blood Units Banked Between 2017 and 2024
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Ex Vivo and In Vivo Potency of CD34+ Hematopoietic Stem and Progenitor Cells Isolated from Cord Blood Using a Novel Technology
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Oral Abstract Session - Advances in Cord Blood Therapy
  • 10:00 AM - 11:30 AM  PT
    AM25-MN-18-L - Umbilical Cord Blood Transplantation (UCBT) a Very Good Curative Option for Pediatric Patients with Congenital Disorders Even in the Setting of Underrepresented Minorities
  • 11:30 AM - 1:00 PM  PT
    Attendee Lunch
  • 11:30 AM - 1:00 PM  PT
    Physicians Leadership Roundtable
  • 12:00 PM - 1:00 PM  PT
    Annual Meeting Education Committee Meeting
  • 12:05 PM - 1:30 PM  PT
    Transfusion Medicine Coordinating Committee and John Elliott Memorial Award Meeting
  • 12:05 PM - 1:45 PM  PT
    Quality and Regulatory Subsection Meeting
  • 12:05 PM - 1:55 PM  PT
    Global Transfusion Forum Meeting
  • 12:30 PM - 1:30 PM  PT
    AABB Transfusion Transmitted Diseases Committee Meeting
  • 2:30 PM - 3:30 PM  PT
    “I Want It That Way” - Ethical Dilemmas in Pediatric Transfusion Medicine
  • 2:30 PM - 3:30 PM  PT
    Advances in Labeling: Practical Applications of 2-D Data Matrix Symbols with ISBT 128
  • 2:30 PM - 3:30 PM  PT
    Advancing Cord Blood Utilization: Building Pathways for Innovation and Clinical Adoption
  • 2:30 PM - 3:30 PM  PT
    From Blueprint to Benchmark: A Journey Through AABB Standards Development and Accreditation
  • 2:30 PM - 3:30 PM  PT
    From Fellow to Faculty: Practical Insights for Trainees and Early Career Physicians
  • 2:30 PM - 3:30 PM  PT
    Uncovering New Blood Groups: Impacts in Transfusion and Beyond (Sally Frank Award and Lectureship)
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Blood Resource Allocation in Oklahoma: A Geospatial Analysis on Available Blood Supply and Potential Networks of Distribution
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Evaluating Immersive Virtual Reality as a Training Tool for Crossmatching in Transfusion Laboratories
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Oral Abstract Session - Application of Novel Technology in Transfusion Medicine
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - Prospective Validation of an Artificial Intelligence Clinical Decision Support System for Preoperative Blood Orders
  • 2:30 PM - 3:30 PM  PT
    AM25-MN-19-L - TransfusaScope: Visualizing the Physiologic Response — Before, During, and After Transfusion
  • 3:45 PM - 4:45 PM  PT
    Ask the Standards
  • 3:45 PM - 4:45 PM  PT
    Blood Bank IT: Compliance and Data Management Concepts
  • 3:45 PM - 4:45 PM  PT
    Plasma Failure in Multiple Organ Dysfunction Syndrome (MODS)
  • 3:45 PM - 4:45 PM  PT
    The Top Nonconformances Stratified by Facility Size and Location. Where Do You Fit?
  • 3:45 PM - 4:45 PM  PT
    Transfusing Safely and Wisely: Much Progress But Still Need to Do Better (Emily Cooley Memorial Award and Lectureship)
  • 3:45 PM - 4:45 PM  PT
    Transfusion Medicine Education for Physicians: Ready-to-Use, Customizable, and Innovative Teaching Tools
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-20-L - Novel JK*A(160T) Identified in a Pediatric Patient with Anti-Jka: Evidence from Family-Based Investigation
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-20-L - Oral Abstract Session - New Variants in Kid & ABO
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-20-L - Variants Causing Altered Expression of ABO Antigens
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Hemostatic Efficacy of Prothrombin Complex Concentrate for Managing Coagulopathic Bleeding in Surgical Patients: Results from the LEX-209 and LEX-211 (FARES-II) Phase 3 Trials
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Impact and Frequency of Intravenous Fluid Contamination of Complete Blood Counts: A Multicenter Retrospective Study: 'Times New Roman',serif; Mso-fareast-font-family: 'Times New Roman'; Color: Black; Mso-themecolor: text1; Mso-font-kerning: 0pt; Mso-ligatures: None;">
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Oral Abstract Session - Hematology & Coagulation
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Rapidly Fatal Adult Case of Ceftriaxone-Induced Immune Hemolytic Anemia
  • 3:45 PM - 4:45 PM  PT
    AM25-MN-21-L - Use of Sutimlimab to Treat a Complement Binding Auto-anti-AnWj Antibody in a Patient with Refractory B-Cell Lymphoma
  • 3:45 PM - 6:00 PM  PT
    CBC: State of the Science Symposium – Striking a New Cord in the Evolution of Stem Cell Transplant (sponsored by Gamida Cell)
  • 5:00 PM - 6:00 PM  PT
    A Tale of Twice-Annual Verification: Why Two Matter, and Who’s Looking?
  • 5:00 PM - 6:00 PM  PT
    CABP Prep
  • 5:00 PM - 6:00 PM  PT
    Computer Systems Under Attack: Cybersecurity Best Practices and Lessons Learned
  • 5:00 PM - 6:00 PM  PT
    Crossmatch Incompatible Transfusions: How Collaboration Between Transfusion Services and Immunohematology Reference Laboratories Enhance Patient Safety
  • 5:00 PM - 6:00 PM  PT
    Debate: Therapeutic Leukapheresis in Hyperleukocytosis—Data-Driven or Dubious?
  • 5:00 PM - 6:00 PM  PT
    Safety, Standards, and Sanity: Navigating Compliance in Emergent Blood Product Release
  • 5:00 PM - 6:00 PM  PT
    Unlocking the Power of Extracellular Vesicles: From Intercellular Communication to Therapeutic Innovation
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - A Randomized, Controlled Pilot Clinical Trial of Extended-stored Cold-stored Platelets in 100% Plasma for Cardiothoracic Surgical Bleeding: The CHASE Trial
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - Donor Genetics and Storage Conditions Influence Mitochondrial DNA Levels in RBC Units
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - Oral Abstract Session - New Insights into Components, Storage, and Patient Outcomes
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - Oxygen-Restricted, Cold Storage Preserves Platelet Function and Count Amid Divergent Oxidative Stress Responses
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-35-L - The Impact of Donor Sex on Platelet Hemostatic Function During 21-Day Cold Storage: Insights from the Chilled Platelet Study in Vitro (CHIPSiv)
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Asian-type DEL Among D-Negative Patients and Donors in Malaysia Can Ease the Demand for D-Negative Red Cells and RhIG
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Growing a RH Variant Donor Database to Meet the Demands for RH Allele-Matched Requests
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Molecular Characterization of Variant D Antigen Expression Among 56,445 Blood Donors in East India
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Oral Abstract Session - Novel RHD Variants and Approaches to Overcoming Them
  • 5:00 PM - 6:00 PM  PT
    AM25-MN-36-L - Partial RHD Genotypes in Genetic-Ancestry Genome Databases
  • 6:15 PM - 7:30 PM  PT
    Research and Progress (RAPS): Organoids in Research and Biotherapies: Promise, Progress, and Challenges
  • 7:30 PM - 9:30 PM  PT
    President's Reception
  • Tuesday, October 28, 2025
  • 6:30 AM - 11:00 AM  PT
    REGISTRATION
  • 7:00 AM - 11:00 AM  PT
    Speaker Ready Room
  • 7:30 AM - 11:30 AM  PT
    Bookstore and AABB Central
  • 7:30 AM - 12:15 PM  PT
    Coat and Luggage Check
  • 8:15 AM - 9:15 AM  PT
    Enhancing Perioperative Autologous Transfusion: Bridging the Gap Between Standards and Practice
  • 8:15 AM - 9:15 AM  PT
    Exploring Innovative Strategies for Blood Donor Recruitment and Retention in Developing Countries, Addressing Challenges and Ensuring Sustainable Blood Supply
  • 8:15 AM - 9:15 AM  PT
    Generations Apart and Together: Navigating Today’s Culture to Build a Sustainable Workforce for Your Transfusion Service
  • 8:15 AM - 9:15 AM  PT
    How New Red Cell Antigens Are Identified, Classified, Added to a Blood Group System. or Creating a New Blood Group System, Theory, and Practice
  • 8:15 AM - 9:15 AM  PT
    The Specialization of Hospital Transfusion Committees: Pragmatic Approaches to Increasing Interest and Effectiveness
  • 8:15 AM - 12:15 PM  PT
    The ICCBBA Learning Lab: The ISBT 128 Standard in Action
  • 9:30 AM - 11:00 AM  PT
    2025 Ask the FDA and CMS/CLIA
  • 9:30 AM - 11:00 AM  PT
    Alpha-Gal Syndrome: Can Tick Bites Lead to Life-Threatening Allergic Transfusion Reactions?
  • 9:30 AM - 11:00 AM  PT
    BPDR Demystified: A Practical Guide to Reporting & Preventing Errors
  • 9:30 AM - 11:00 AM  PT
    Building a Translational Arm to Your Cellular Therapy Laboratory
  • 9:30 AM - 11:00 AM  PT
    IRL Accreditation: Case Studies and Helpful Hints for Better Conformance.
  • 9:30 AM - 11:00 AM  PT
    Maximum Surgical Blood Order Schedule (MSBOS): Return on Investment, Implementation, and AI
  • 9:30 AM - 11:00 AM  PT
    Transfusion Medicine, Hemostasis, Apheresis, and Cellular Therapy Review Session for Trainees
  • 9:30 AM - 11:00 AM  PT
    AM25-TU-15-L - Daratumumab Administration Results in Durable Reduction of Isohemagglutinin Titers in ABO-Mismatched Bone Marrow Transplant
  • 9:30 AM - 11:00 AM  PT
    AM25-TU-15-L - Duffy-Null Status and Delayed Neutrophil Engraftment in Autologous Hematopoietic Transplantation: A Call for Awareness
  • 9:30 AM - 11:00 AM  PT
    AM25-TU-15-L - Lack of Transfusion Independence by Day 30 After Allogeneic Hematopoietic Cell Transplant Is Associated with Increased Non-Relapse Mortality Independent of HCT-CI in Acute Myeloid Leukemia Patients
  • 9:30 AM - 11:00 AM  PT
    AM25-TU-15-L - Oral Abstract Spotlight Session - Biotherapies & Cell Transplantation
  • 9:30 AM - 11:00 AM  PT
    AM25-TU-15-L - Using Protein Phosphorylation Network Analysis to Design Neonatal Platelet Transfusion Products
  • 9:30 AM - 11:00 AM  PT
    AM25-TU-20-L - Oral Abstract Session - Therapeutic and Donor Apheresis and Blood Donation Infectious Disease
  • 11:15 AM - 12:15 PM  PT
    The Monocyte Monolayer Assay in Transfusion Medicine: Historical Insights and Clinical Applications
  • 11:15 AM - 12:15 PM  PT
    Transfusion Medicine and Blood Bank Practice Guidelines for Von Willebrand Disease
  • 11:15 AM - 12:15 PM  PT
    Veterinary Transfusion Medicine: An Overview of Blood Banking for Our Furry Friends
  • 11:15 AM - 12:15 PM  PT
    What's New in Transfusion Therapy for Sickle Cell Disease
  • 11:15 AM - 12:15 PM  PT
    Why, When and How Should You Use Electronic Batch Records (EBRs) in the Cell and Gene Therapy Manufacturing Process
  • 3:45 PM - 4:45 PM  PT
    AM25-SN-20-L - Blood Exchange Transfusion as a Novel Immunotherapy in Systemic Lupus Erythematosus
  • 3:45 PM - 4:45 PM  PT
    AM25-SN-20-L - Evaluation of Lymphoplasmapheresis as a Novel Therapy for Efficacy and Immunomodulatory Mechanisms in Neuromyelitis Optica Spectrum Disorder
  • 3:45 PM - 4:45 PM  PT
    AM25-SN-20-L - HIV Incidence and Factors Associated with Recent Infection Among Blood Donors in Brazil Following Adoption of Individual Donor Assessment
  • 3:45 PM - 4:45 PM  PT
    AM25-SN-20-L - The Effect of Plasma Donation Frequency on Lipid Profile: Results from a Randomized Controlled Study